XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings/(Accumulated deficit)
Retained Earnings/(Accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2021 $ 3,600 $ (43)   $ 4 $ 8,531 $ (100) $ 464 $ 57 $ (5,273) $ (126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (Loss)/ Income 1,736           1,736      
Other comprehensive income 8                 8
Share repurchases (187)               (187)  
Equity-based awards activity, net [1] 2       2          
Common stock dividends and dividend equivalents declared [2] (86)           (86)      
Ending balance at Mar. 31, 2022 5,030     4 8,433   2,171   (5,460) (118)
Beginning balance at Dec. 31, 2022 3,828   $ 0 4 8,457   1,408   (5,864) (177)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (Loss)/ Income (1,335)           (1,335)      
Issuance of Series A Preferred Stock 636   650   (14)          
Other comprehensive income 1                 1
Equity-based awards activity, net [1] 38       38          
Common stock dividends and dividend equivalents declared [2] (88)           (88)      
Ending balance at Mar. 31, 2023 $ 3,080   $ 650 $ 4 $ 8,481   $ (15)   $ (5,864) $ (176)
[1] Includes $(8) million and $(6) million of equivalent shares purchased in lieu of tax withholding on equity compensation issuances for the quarters ended March 31, 2023 and 2022, respectively.
[2] Dividends per common share were $0.3775 and $0.35 for the quarters ended March 31, 2023 and 2022.